Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma: Final report of RTOG 9404 Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Astrocytoma
  • Brain Neoplasms
  • Bromodeoxyuridine
  • Radiation-Sensitizing Agents

abstract

  • No survival advantage was noted by adding BUdR to EBRT and PCV in this patient population

publication date

  • March 15, 2004

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.ijrobp.2003.08.024

PubMed ID

  • 15001257

Additional Document Info

start page

  • 1147

end page

  • 52

volume

  • 58

number

  • 4